BLRX BioLineRx
BioLineRx earnings company data as of 4:49 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 23 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 31 Aug | EPS | 0.00 | -1.00 | — |
| Rev | $500.0K | $300.0K | Miss |
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 424B3 | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 424B5 | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F/A | 20F/A | Filing Doc | |
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 424B5 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.